控制心脏死亡后与延迟移植功能和捐赠者的移植存活相关的因素
María Amalia Tárraga-Honrubia1, Pedro Carrión-López1,2, Daniel Sánchez-Villaescusa3
1Urology Department, Hospital and University Complex of Albacete, 02006 Albacete, Spain.
Archivos espanoles de urologia
|September 9, 2025
概括
从心脏死亡捐赠者的移植中延迟的移植功能与长期存活率的减少有关. 优化输液技术和减少温暖缺血时间可以降低其发生率,改善移植患者的结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 移植手术 移植手术
- 器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器
背景情况:
- 延迟移植功能 (DGF) 是移植的重要并发症,增加了长期移植拒绝和损失的风险.
- 由于控制心脏死亡 (DCD) 后捐赠脏的使用增加,DGF的发病率正在上升.
- 了解DGF的贡献因素对于改善移植存活率至关重要.
研究的目的:
- 为了确定与DCD捐赠者的脏移植中延迟移植功能的出现相关的因素.
- 确定这些已识别的因素如何影响长期移植存活率.
- 为减少GDF发病率和改善移植结果提供见解.
主要方法:
- 从2013年3月至2023年12月期间从DCD捐赠者进行的移植的回顾性分析.
- 收集的数据包括DGF存在,移植存活率,供体和受体特征,收获技术,缺血时间和手术并发症.
- 采用多变量分析来确定DGF的独立预测因子及其对移植存活的影响.
主要成果:
- 延迟的移植功能发生在38.9%的患者中.
- 与DGF显著相关的因素包括更长的透析时间,糖尿病的捐赠者史,更高的移植活检得分,使用超快的收获技术和更长的温暖缺血时间.
- 虽然DGF并没有显著增加整体移植损失,但它与较高的晚期移植损失率 (16.7%与4.1%) 有关.
结论:
- 来自DCD捐赠者的移植中移植功能的延迟与长期移植存活率的降低有关.
- 优化输液策略 (例如,体外膜氧化),采用特定的收获技术,并最大限度地减少温暖缺血时间可以减少DGF的发生率.
- 这些发现突出了可修改的因素,以改善移植接受者的结果.
关键词:
延迟的移植功能 延迟的移植功能植入物生存率 植入物生存率心脏停止了,心脏停止了.器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器移植 移植 移植更多相关视频
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
2.3K
07:08A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
Published on: June 6, 2025
589
相关概念视频
01:28Kidney Transplant I: Introduction
349
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
349
01:26Kidney Transplant II: Surgical Procedure
325
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
325
01:24Tissue Transplantation
928
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
928
01:16Kidney Transplant III: Nursing Management
321
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
321